Anti-FR1L5/ FER1L5 monoclonal antibody

Anti-FR1L5/ FER1L5 antibody for FACS & in-vivo assay

Target products collectionGo to FER1L5/FER1L5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0441-Ab-1/ GM-Tg-hg-MP0441-Ab-2Anti-Human FER1L5 monoclonal antibodyHuman
GM-Tg-rg-MP0441-Ab-1/ GM-Tg-rg-MP0441-Ab-2Anti-Rat FER1L5 monoclonal antibodyRat
GM-Tg-mg-MP0441-Ab-1/ GM-Tg-mg-MP0441-Ab-2Anti-Mouse FER1L5 monoclonal antibodyMouse
GM-Tg-cynog-MP0441-Ab-1/ GM-Tg-cynog-MP0441-Ab-2Anti-Cynomolgus/ Rhesus macaque FER1L5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0441-Ab-1/ GM-Tg-felg-MP0441-Ab-2Anti-Feline FER1L5 monoclonal antibodyFeline
GM-Tg-cang-MP0441-Ab-1/ GM-Tg-cang-MP0441-Ab-2Anti-Canine FER1L5 monoclonal antibodyCanine
GM-Tg-bovg-MP0441-Ab-1/ GM-Tg-bovg-MP0441-Ab-2Anti-Bovine FER1L5 monoclonal antibodyBovine
GM-Tg-equg-MP0441-Ab-1/ GM-Tg-equg-MP0441-Ab-2Anti-Equine FER1L5 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0441-Ab-1/ GM-Tg-hg-MP0441-Ab-2; GM-Tg-rg-MP0441-Ab-1/ GM-Tg-rg-MP0441-Ab-2;
GM-Tg-mg-MP0441-Ab-1/ GM-Tg-mg-MP0441-Ab-2; GM-Tg-cynog-MP0441-Ab-1/ GM-Tg-cynog-MP0441-Ab-2;
GM-Tg-felg-MP0441-Ab-1/ GM-Tg-felg-MP0441-Ab-2; GM-Tg-cang-MP0441-Ab-1/ GM-Tg-cang-MP0441-Ab-2;
GM-Tg-bovg-MP0441-Ab-1/ GM-Tg-bovg-MP0441-Ab-2; GM-Tg-equg-MP0441-Ab-1/ GM-Tg-equg-MP0441-Ab-2
Products NameAnti-FER1L5 monoclonal antibody
Formatmab
Target NameFER1L5
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FER1L5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FR1L5/ FER1L5 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0441
    Target NameFER1L5
    Gene ID90342,100534273,679806,709889,481347,101097802,526655,100062182
    Gene Symbol and Synonyms4930533C12Rik,FER1L5,Fer1l5-ps1
    Uniprot AccessionA0AVI2
    Uniprot Entry NameFR1L5_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000249715
    Target ClassificationN/A

    The target: FER1L5, gene name: FER1L5, also named as . Predicted to enable calcium ion binding activity and calcium-dependent phospholipid binding activity. Predicted to be involved in several processes, including myeloid cell activation involved in immune response; negative regulation of phagocytosis; and plasma membrane organization. Predicted to be located in plasma membrane. Predicted to be integral component of membrane. Predicted to be active in T-tubule and cytoplasmic vesicle. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.